Differential expression of miRNAs in Exhaled Breath Condensate (EBC) and EBUS-TBNA of patients with Mediastinal Tuberculosis and Pulmonary Sarcoidosis

B. Pattnaik (New Delhi, India), S. Pb (New Delhi, India), S. Mittal (New Delhi, India), A. Mohan (New Delhi, India), A. Agrawal (New Delhi, India), R. Guleria (New Delhi, India), K. Madan (New Delhi, India)

Source: Virtual Congress 2020 – Genetics and biomarkers for diagnosis and prognosis of granulomatous lung diseases
Session: Genetics and biomarkers for diagnosis and prognosis of granulomatous lung diseases
Session type: E-poster session
Number: 1083
Disease area: Respiratory infections, Thoracic oncology

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
B. Pattnaik (New Delhi, India), S. Pb (New Delhi, India), S. Mittal (New Delhi, India), A. Mohan (New Delhi, India), A. Agrawal (New Delhi, India), R. Guleria (New Delhi, India), K. Madan (New Delhi, India). Differential expression of miRNAs in Exhaled Breath Condensate (EBC) and EBUS-TBNA of patients with Mediastinal Tuberculosis and Pulmonary Sarcoidosis. 1083

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Exhaled Breath Biomarkers in Sarcoidosis: A Systematic Review
Source: International Congress 2018 – Granulomatous disorders: heterogeneous diseases with variable management
Year: 2018

Diagnosing Pulmonary Tuberculosis by Pooling Induced Sputum
Source: International Congress 2017 – Microbiology and laboratory techniques to monitor NTM infections
Year: 2017


Correlation between Blood Eosinophilia and Fractional Exhaled Nitric Oxide in the diagnosis of Asthma within Primary Care.
Source: Virtual Congress 2020 – Monitoring of inflammation in remodelling
Year: 2020


Inflammatory markers in the exhaled breath condensate from patients with pulmonary sarcoidosis: comparison with BALF
Source: Eur Respir J 2006; 28: Suppl. 50, 353s
Year: 2006

Changes in PH of exhaled breath condensate after specific inhalation challenge test, in patients with hypersensitivity pneumonitis
Source: International Congress 2014 – ILDs 3
Year: 2014

Late Breaking Abstract - Metabolomics in Exhaled Breath Condensate (EBC) of asthmatic patients. Does severity and methodology make the difference?
Source: International Congress 2017 – Late-breaking findings in asthma and COPD
Year: 2017

Pneumomediastinum following EBUS-TBNA in patients with Pulmonary Fibrosis
Source: International Congress 2017 – EBUS
Year: 2017


Serum levels of sestrin 2 in patients with sarcoidosis
Source: International Congress 2014 – ILDs 6
Year: 2014


Exhaled breath condensate pH in assessment of childhood asthma control
Source: International Congress 2014 – Asthma or COPD: comorbid condition or a poorly understood single disease?
Year: 2014

Exhaled Breath Analysis for Prediction of Response to Anti-PD1 Therapy in Patients with NSCLC
Source: International Congress 2017 – Lung cancer: clinical research on exhaled breath, clinical trials in advanced NSCLC and real-life appraisals of immunotherapies
Year: 2017



Exhaled breath: Non-invasive diagnosis of ventilator-associated pneumonia
Source: International Congress 2015 – Prognostic factors in pneumonia: from clinical observations to experimental models
Year: 2015


Comparison of eicosanoids in sputum, bronchoalveolar lavage and exhaled breath condensate
Source: International Congress 2014 – Airway biomarkers
Year: 2014

Exhaled breath analysis using eNose technology in patients with sarcoidosis
Source: Virtual Congress 2020 – Sarcoidosis: from genetics to epidemiology
Year: 2020




Exhaled breath condensate pH in exercise-induced bronchoconstriction
Source: International Congress 2014 – Systemic and airway biomarkers
Year: 2014


Detection of exosomal miRNA in pulmonary sarcoidosis
Source: International Congress 2014 – Novel epigenetic regulators for targeting via nanomedicine
Year: 2014


Inflammatory markers in exhaled breath condensate in bronchiectasis
Source: Eur Respir J 2004; 24: Suppl. 48, 707s
Year: 2004

Comparison of Fractional Nitric Oxide in Exhaled Breath in bronchial asthma and COPD
Source: International Congress 2017 – Classifying COPD with multidimensional scores and biomarkers
Year: 2017

Exhaled particles as markers of small airways inflammation in asthmatic subjects
Source: International Congress 2014 – Systemic and airway biomarkers
Year: 2014


Exhaled Breath Analysis for the Diagnosis of Obstructive Sleep Apnea
Source: International Congress 2018 – Sleep-disordered breathing: biomarkers and genetics and the role of hypoxia, insomnia, movement disorders and sleep quality
Year: 2018


Exhaled breath condensate hydrogen peroxide in obstructive airways disease
Source: International Congress 2014 – Airway biomarkers
Year: 2014